about
Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOFEpigenetic regulation in hepatocellular carcinoma requires long noncoding RNAsEvidence for a common progenitor of epithelial and mesenchymal components of the liver.Searching for DNA-protein interactions by lambda phage display.Human haemato-endothelial precursors: cord blood CD34+ cells produce haemogenic endotheliumIdentification of a bipotential precursor cell in hepatic cell lines derived from transgenic mice expressing cyto-Met in the liverElucidation of lipoprotein particles structure by proteomic analysis.Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte.Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload.Ferritin heavy chain is the host factor responsible for HCV-induced inhibition of apoB-100 production and is required for efficient viral infection.The new murine hepatic 3A cell line responds to stress stimuli by activating an efficient Unfolded Protein Response (UPR).The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α.Proteomic analysis reveals a major role for contact inhibition in the terminal differentiation of hepatocytes.TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.Oxidation affects the regulation of hepatic lipid synthesis by chylomicron remnants.Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29.An epistatic mini-circuitry between the transcription factors Snail and HNF4α controls liver stem cell and hepatocyte features exhorting opposite regulation on stemness-inhibiting microRNAs.Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice.Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation.Isolation and characterization of a murine resident liver stem cell.Human αl-antitrypsin: molecular diagnosis of mutation and animal models of human pathology
P50
Q24323213-8947B085-E130-4831-8A0A-38A58DD603BBQ28084553-78E2F960-3A41-4F81-BC38-D2E66AA9C59BQ30541269-D5E78883-DCBA-4719-B047-03F9200D3251Q31110525-402814F8-328A-4E52-B23C-8E8D785B19AFQ34506724-5678B34E-51A9-4AE2-A174-65288DCBB0C5Q36255868-54009C6D-BE2B-41E5-ADBA-164228EC7D25Q37087392-114AEAE4-742F-4163-AEA9-21C9C2BA545DQ38207092-76BEFB0C-4080-4D75-9B95-449812B9A7BAQ39016620-AF24C3D7-35CE-43BC-9D95-8C04EE089E59Q39374849-6B06124F-5E9D-4210-9E45-8C89236164BEQ39457508-65FA724A-155D-488F-9456-F1D3B37D4E1AQ39579573-1B3DFF0D-36D0-426C-B31A-206387D25DF8Q39759737-F36D34B8-DCF3-497F-A581-CC50D83A54C0Q40065091-B68EED0C-149E-45A4-9991-F3BEA0F70F76Q40826820-088812D8-D1B7-46C4-AC88-428DE22BAA5CQ41205601-F04E0C3A-49F4-426C-BC3F-314FEA4FF45BQ42096394-128A1E54-A770-4AE6-B2D3-1E27463411ADQ42628139-C6E15B3A-CC72-4A28-8333-532449787507Q47767379-6E6715A3-C2CE-45CA-B2B5-3408F8D1575BQ51975270-C2CC5DAC-8ABF-4459-92FD-966E410F86DEQ61890292-21D22F40-D751-4E08-8FF2-34F7EC040622
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Laura Amicone
@ast
Laura Amicone
@en
Laura Amicone
@es
Laura Amicone
@nl
Laura Amicone
@sl
type
label
Laura Amicone
@ast
Laura Amicone
@en
Laura Amicone
@es
Laura Amicone
@nl
Laura Amicone
@sl
prefLabel
Laura Amicone
@ast
Laura Amicone
@en
Laura Amicone
@es
Laura Amicone
@nl
Laura Amicone
@sl
P106
P1153
6602922833
P21
P31
P496
0000-0002-3487-5740